Vanderbilt University Med.Center -Treatment & Research Inst. For Asd — Nashville, Tennessee

Vanderbilt University Med.Center -Treatment & Research Inst. For Asd is a clinical research site located in Nashville, Tennessee, United States 37232-2551.

Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Vanderbilt University Med.Center -Treatment & Research Inst. For Asd has participated in 1 clinical trials.

Therapeutic areas: Autism.

Sponsors: Curemark.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt University Med.Center -Treatment & Research Inst. For Asd?

Vanderbilt University Med.Center -Treatment & Research Inst. For Asd has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt University Med.Center -Treatment & Research Inst. For Asd conducted?

Vanderbilt University Med.Center -Treatment & Research Inst. For Asd has 1 clinical trials on record. Their work covers Autism.

Is Vanderbilt University Med.Center -Treatment & Research Inst. For Asd accredited by Crixeo Clinical Trials?

Vanderbilt University Med.Center -Treatment & Research Inst. For Asd has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt University Med.Center -Treatment & Research Inst. For Asd?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.